W. David Mello, M.d., Inc.,a Professional Corporation | |
1818 Verdugo Blvd Ste 107 Glendale CA 91208-1400 | |
(818) 790-0122 | |
(818) 790-4623 |
Full Name | W. David Mello, M.d., Inc.,a Professional Corporation |
---|---|
Speciality | Internal Medicine |
Location | 1818 Verdugo Blvd Ste 107, Glendale, California |
Authorized Official Name and Position | Barbara Susan Mello (OFFICE MANAGER/CFO) |
Authorized Official Contact | 8187900122 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
W. David Mello, M.d., Inc.,a Professional Corporation 1818 Verdugo Blvd Ste 107 Glendale CA 91208-1400 Ph: (818) 790-0122 | W. David Mello, M.d., Inc.,a Professional Corporation 1818 Verdugo Blvd Ste 107 Glendale CA 91208-1400 Ph: (818) 790-0122 |
NPI Number | 1073214060 |
---|---|
Provider Enumeration Date | 03/15/2023 |
Last Update Date | 05/01/2023 |
Medicare PECOS PAC ID | 9931565686 |
---|---|
Medicare Enrollment ID | O20230523000128 |
News Archive
PPD, today announced it has established a joint venture with Taijitu Biologics Limited in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD's capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe.
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.
Alere Health, LLC, a leader in personal health support solutions, today announced a partnership between the Alere® Women's & Children's Health Division and UK-based Monica Healthcare Ltd, developers of a groundbreaking wireless, wearable fetal-maternal monitor.
Chevy Chase, MD-Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response. Seeking to address this critical health issue, an international multidisciplinary group of experts just issued recommendations for individualized treatment in a consensus statement to be published in the April 2010 issue of the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1073214060 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
Provider Name | W. David Mello |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1376549733 PECOS PAC ID: 3274620299 Enrollment ID: I20101123000057 |
News Archive
PPD, today announced it has established a joint venture with Taijitu Biologics Limited in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD's capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe.
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.
Alere Health, LLC, a leader in personal health support solutions, today announced a partnership between the Alere® Women's & Children's Health Division and UK-based Monica Healthcare Ltd, developers of a groundbreaking wireless, wearable fetal-maternal monitor.
Chevy Chase, MD-Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response. Seeking to address this critical health issue, an international multidisciplinary group of experts just issued recommendations for individualized treatment in a consensus statement to be published in the April 2010 issue of the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
› Verified 5 days ago
News Archive
PPD, today announced it has established a joint venture with Taijitu Biologics Limited in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD's capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe.
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.
Alere Health, LLC, a leader in personal health support solutions, today announced a partnership between the Alere® Women's & Children's Health Division and UK-based Monica Healthcare Ltd, developers of a groundbreaking wireless, wearable fetal-maternal monitor.
Chevy Chase, MD-Patients with type 2 diabetes are generally treated similarly despite the fact that they may have underlying differences that could affect their therapeutic response. Seeking to address this critical health issue, an international multidisciplinary group of experts just issued recommendations for individualized treatment in a consensus statement to be published in the April 2010 issue of the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
› Verified 5 days ago
Silva Karchikian, M.d. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 410 Arden Ave, Suite 101, Glendale, CA 91203 Phone: 818-549-9305 Fax: 818-662-8812 | |
Glendale Premier Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W Eulalia St, #201, Glendale, CA 91204 Phone: 818-240-0601 Fax: 818-240-0687 | |
Glenoaks Urgent Care Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1100 W Glenoaks Blvd, Glendale, CA 91202 Phone: 818-242-3333 Fax: 818-546-1056 | |
Rubin Manavi, Md, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 N Central Ave, Glendale, CA 91203 Phone: 818-241-0970 Fax: 818-638-0024 | |
Armen Nercessian Do Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1122 N Brand Blvd Ste 101, Glendale, CA 91202 Phone: 818-552-2011 Fax: 818-552-2012 | |
Synergy Observation Specialists Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Andy Chen M.d. A,medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1101 N Pacific Ave Ste 104, Glendale, CA 91202 Phone: 818-552-5000 Fax: 818-552-2959 |